Bibliography | CPRD

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

CPRD bibliography

CPRD bibliography

(PDF, 5MB, 226 pages)

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.

Export 29 results:

Filters: Author is Douglas, I. J. [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A

K. E. Mansfield, Douglas, I. J., Nitsch, D., Thomas, S. L., Smeeth, L., and Tomlinson, L. A., “Acute kidney injury and infections in patients taking antihypertensive drugs: a self-controlled case series analysis”, Clin Epidemiol, vol. 10, pp. 187-202, 2018.

K. L. Goh, Bhaskaran, K., Minassian, C., Evans, S. J., Smeeth, L., and Douglas, I. J., “Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink”, Br J Clin Pharmacol, vol. 79, pp. 337-50, 2015.

C. S. Chui, Chan, E. W., Wong, A. Y., Root, A., Douglas, I. J., and Wong, I. C., “Association between oral fluoroquinolones and seizures: A self-controlled case series study”, Neurology, vol. 86, pp. 1708-15, 2016.

K. Bhaskaran, dos-Santos-Silva, I., Leon, D. A., Douglas, I. J., and Smeeth, L., “Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3.6 million adults in the UK”, Lancet Diabetes Endocrinol, vol. 6, pp. 944-953, 2018.

A. Root, Brown, J. P., Forbes, H. J., Bhaskaran, K., Hayes, J., Smeeth, L., and Douglas, I. J., “Association of Relative Age in the School Year With Diagnosis of Intellectual Disability, Attention-Deficit/Hyperactivity Disorder, and Depression”, JAMA Pediatr, 2019.

B

I. J. Douglas, Bhaskaran, K., Batterham, R. L., and Smeeth, L., “Bariatric Surgery in the United Kingdom: A Cohort Study of Weight Loss and Clinical Outcomes in Routine Clinical Care”, PLoS Med, vol. 12, p. e1001925, 2015.

C

I. J. Douglas, Cook, C., Chakravarthy, U., Hubbard, R., Fletcher, A. E., and Smeeth, L., “A case-control study of drug risk factors for age-related macular degeneration”, Ophthalmology, vol. 114, pp. 1164-9, 2007.

F. Nissen, Douglas, I. J., Mullerova, H., Pearce, N., Bloom, C. I., Smeeth, L., and Quint, J. K., “Clinical profile of predefined asthma phenotypes in a large cohort of UK primary care patients (Clinical Practice Research Datalink)”, J Asthma Allergy, vol. 12, pp. 7-19, 2019.

I. J. Douglas, Evans, S. J., Hingorani, A. D., Grosso, A. M., Timmis, A., Hemingway, H., and Smeeth, L., “Clopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designs”, Bmj, vol. 345, p. e4388, 2012.

S. J. Sinnott, Smeeth, L., Williamson, E., Perel, P., Nitsch, D., Tomlinson, L. A., and Douglas, I. J., “The comparative effectiveness of fourth-line drugs in resistant hypertension: An application in electronic health record data”, Pharmacoepidemiol Drug Saf, 2019.

S. Wilkinson, Williamson, E., Pokrajac, A., Fogarty, D., Stirnadel-Farrant, H., Smeeth, L., Douglas, I. J., and Tomlinson, L. A., “Comparative effects of sulfonylureas, DPP4is and SGLT2 inhibitors added to metformin monotherapy: a propensity-score matched cohort study in UK primary care”, Diabetes Obes Metab, 2020.

P. Bidulka, Iwagami, M., Mansfield, K. E., Kalogirou, F., Wong, A. Y. S., Douglas, I. J., Smeeth, L., Summers, C., and Tomlinson, L. A., “Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study”, Wellcome Open Res, vol. 5, p. 77, 2020.

F. Nissen, Morales, D. R., Mullerova, H., Smeeth, L., Douglas, I. J., and Quint, J. K., “Concomitant diagnosis of asthma and COPD: a quantitative study in UK primary care”, Br J Gen Pract, vol. 68, pp. e775-e782, 2018.

E

I. J. Douglas, Bhaskaran, K., Batterham, R. L., and Smeeth, L., “The effectiveness of pharmaceutical interventions for obesity: weight loss with orlistat and sibutramine in a United Kingdom population-based cohort”, Br J Clin Pharmacol, vol. 79, pp. 1020-7, 2015.

C. I. Bloom, Nissen, F., Douglas, I. J., Smeeth, L., Cullinan, P., and Quint, J. K., “Exacerbation risk and characterisation of the UK's asthma population from infants to old age”, Thorax, vol. 73, pp. 313-320, 2018.

I. J. Douglas and Smeeth, L., “Exposure to antipsychotics and risk of stroke: self controlled case series study”, Bmj, vol. 337, p. a1227, 2008.

F

S. Wilkinson, Douglas, I. J., Williamson, E., Stirnadel-Farrant, H. A., Fogarty, D., Pokrajac, A., Smeeth, L., and Tomlinson, L. A., “Factors associated with choice of intensification treatment for type 2 diabetes after metformin monotherapy: a cohort study in UK primary care”, Clin Epidemiol, vol. 10, pp. 1639-1648, 2018.

G

M. Iwagami, Tomlinson, L. A., Mansfield, K. E., Douglas, I. J., Smeeth, L., and Nitsch, D., “Gastrointestinal bleeding risk of selective serotonin reuptake inhibitors by level of kidney function: A population-based cohort study”, Br J Clin Pharmacol, vol. 84, pp. 2142-2151, 2018.

I

J. Tazare, Smeeth, L., Evans, S. J. W., Williamson, E., and Douglas, I. J., “Implementing high-dimensional propensity score principles to improve confounder adjustment in UK electronic health records”, Pharmacoepidemiol Drug Saf, 2020.

L

T. A. Yates, Tomlinson, L. A., Bhaskaran, K., Langan, S., Thomas, S., Smeeth, L., and Douglas, I. J., “Lansoprazole use and tuberculosis incidence in the United Kingdom Clinical Practice Research Datalink: A population based cohort”, PLoS Med, vol. 14, p. e1002457, 2017.

U. Koppe, Nitsch, D., Mansfield, K. E., Mathur, R., Bhaskaran, K., Batterham, R. L., Smeeth, L., and Douglas, I. J., “Long-term effects of bariatric surgery on acute kidney injury: a propensity-matched cohort in the UK Clinical Practice Research Datalink”, BMJ Open, vol. 8, p. e020371, 2018.

O

I. J. Douglas, Langham, J., Bhaskaran, K., Brauer, R., and Smeeth, L., “Orlistat and the risk of acute liver injury: self controlled case series study in UK Clinical Practice Research Datalink”, Bmj, vol. 346, p. f1936, 2013.

P

A. Matthews, Langan, S. M., Douglas, I. J., Smeeth, L., and Bhaskaran, K., “Phosphodiesterase Type 5 Inhibitors and Risk of Malignant Melanoma: Matched Cohort Study Using Primary Care Data from the UK Clinical Practice Research Datalink”, PLoS Med, vol. 13, p. e1002037, 2016.

J. P. Brown, Tazare, J. R., Williamson, E., Mansfield, K. E., Evans, S. J., Tomlinson, L. A., Bhaskaran, K., Smeeth, L., Wing, K., and Douglas, I. J., “Proton pump inhibitors and risk of all-cause and cause-specific mortality: a cohort study”, Br J Clin Pharmacol, 2021.

R

I. J. Douglas, Evans, S. J., Pocock, S., and Smeeth, L., “The risk of fractures associated with thiazolidinediones: a self-controlled case-series study”, PLoS Med, vol. 6, p. e1000154, 2009.

T

S. J. Sinnott, Smeeth, L., Williamson, E., and Douglas, I. J., “Trends for prevalence and incidence of resistant hypertension: population based cohort study in the UK 1995-2015”, Bmj, vol. 358, p. j3984, 2017.

E. Crellin, Mansfield, K. E., Leyrat, C., Nitsch, D., Douglas, I. J., Root, A., Williamson, E., Smeeth, L., and Tomlinson, L. A., “Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study”, Bmj, vol. 360, p. k341, 2018.

V

F. Nissen, Morales, D. R., Mullerova, H., Smeeth, L., Douglas, I. J., and Quint, J. K., “Validation of asthma recording in the Clinical Practice Research Datalink (CPRD)”, BMJ Open, vol. 7, p. e017474, 2017.

[Page last reviewed 6 April 2021]